FindTrial
Sign In

Comparing the pain releiving effect of two concentrations of Levobupivacaine in scan guided type 2 Quadratus lumborum block in patients undergoing Gall bladder removal surgery

Comparison of Analgesic efficacy of two different concentrations of Levobupivacaine in Ultrasound guided Type 2 Quadratus Lumborum block in Laparoscopic Cholecystectomy- A randomized controlled trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/049741
Enrollment
60
Registered
2023-02-15
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K802- Calculus of gallbladder without cholecystitis Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: 30 ml of 0.125% Levobupivacaine each side: Type 2 Quadratus Lumborum block will be given after Induction of Anaesthesia. In Intervention group 30 ml of 0.125% Levobupivacaine will be gi

Sponsors

Institue of Liver and Biliary Sciences ILBS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of age 18-65 years, either sex, weighing between 50 to 70 kgs, ASA (American Society of Anaesthesiology) class I/ II.

Exclusion criteria

Exclusion criteria: Patient refusal Patients with known history of LA allergy, psychiatric illness, substance abuse, opioid tolerance. Any uncompensated systemic illness (cardiovascular, respiratory, metabolic, neurologic and endocrine). Patient with Liver disease.

Design outcomes

Primary

MeasureTime frame
Post operative Fentanyl consumption by Numerical Rating Scale.Timepoint: Post operative 0,2,4,6,12 and 24 hours—

Secondary

MeasureTime frame
Duration of Analgesia- time from block to first rescue analgesiaTimepoint: Post operative time 24 hours;Pain score by Numerical Rating Scale. Timepoint: Post operative 0,2,4,6,12 and 24 hours;Side effectsTimepoint: Postoperative time 24 hours;Total intraoperative fentanyl consumptionTimepoint: during surgery—

Countries

India

Contacts

Public ContactDr Saravanan M

Institute of Liver and Biliary Sciences

shivalipanwar@gmail.com9818241779

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026